{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:31:47Z","timestamp":1762446707189,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024075","name":"Region Syddanmark","doi-asserted-by":"publisher","award":["373","731"],"award-info":[{"award-number":["373","731"]}],"id":[{"id":"10.13039\/501100024075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007214","name":"Velux Foundation","doi-asserted-by":"publisher","award":["25723"],"award-info":[{"award-number":["25723"]}],"id":[{"id":"10.13039\/100007214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004196","name":"Odense Universitetshospital","doi-asserted-by":"publisher","award":["4038"],"award-info":[{"award-number":["4038"]}],"id":[{"id":"10.13039\/501100004196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0069586"],"award-info":[{"award-number":["0069586"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bonr.2023.101703","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:23:19Z","timestamp":1689996199000},"page":"101703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection \u2013 A post-treatment re-initiation bone biopsy-based case study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-1977","authenticated-orcid":false,"given":"Louise Alstrup","family":"Drejer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4963-4859","authenticated-orcid":false,"given":"Bilal Mohamad","family":"El-Masri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3162-0793","authenticated-orcid":false,"given":"Charlotte","family":"Ejersted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-5677","authenticated-orcid":false,"given":"Christina M\u00f8ller","family":"Andreasen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-5974","authenticated-orcid":false,"given":"Lisbeth Koch","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-6679","authenticated-orcid":false,"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-7276","authenticated-orcid":false,"given":"Thomas Levin","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9486-0316","authenticated-orcid":false,"given":"Stinus","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2023.101703_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/832127","article-title":"Bone loss triggered by the cytokine network in inflammatory autoimmune diseases","volume":"2015","author":"Amarasekara","year":"2015","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0010","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00198-015-3459-5","article-title":"Multiple clinical vertebral fractures following denosumab discontinuation","volume":"27","author":"Anastasilakis","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bonr.2023.101703_bb0015","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajpath.2013.03.006","article-title":"Understanding coupling between bone resorption and formation: are reversal cells the missing link?","volume":"183","author":"Andersen","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bonr.2023.101703_bb0025","series-title":"Osteoporotic Fracture and Systemic Skeletal Disorders: Mechanism, Assessment, and Treatment","first-page":"101","article-title":"Significance of reversal-resorption phase in bone loss","author":"Andersen","year":"2022"},{"issue":"4","key":"10.1016\/j.bonr.2023.101703_bb0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/jbmr.3354","article-title":"Understanding age-induced cortical porosity in women: the accumulation and coalescence of eroded cavities upon existing Intracortical canals is the main contributor","volume":"33","author":"Andreasen","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2023.101703_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bone.2018.09.011","article-title":"Understanding age-induced cortical porosity in women: is a negative BMU balance in quiescent osteons a major contributor?","volume":"117","author":"Andreasen","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2023.101703_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115127","article-title":"The generation of enlarged eroded pores upon existing intracortical canals is a major contributor to endocortical trabecularization","volume":"130","author":"Andreasen","year":"2020","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0045","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s00198-015-3380-y","article-title":"Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports","volume":"27","author":"Aubry-Rozier","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2023.101703_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2016.07.003","article-title":"Osteocyte lacunar properties and cortical microstructure in human iliac crest as a function of age and sex","volume":"91","author":"Bach-Gansmo","year":"2016","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.bonr.2023.101703_bb0055","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jbmr.3561","article-title":"Intracortical Bone mechanics are related to pore morphology and remodeling in human bone","volume":"33","author":"Bakalova","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bonr.2023.101703_bb0060","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bonr.2023.101703_bb0065","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.bonr.2023.101703_bb0070","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/jbmr.448","article-title":"Bone remodeling in postmenopausal women who discontinued denosumab treatment: off-treatment biopsy study","volume":"26","author":"Brown","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11914-016-0319-y","article-title":"Cortical bone porosity: what is it, why is it important, and how can we detect it?","volume":"14","author":"Cooper","year":"2016","journal-title":"Curr. Osteoporos Rep."},{"issue":"8","key":"10.1016\/j.bonr.2023.101703_bb0080","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bonr.2023.101703_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2023.101703_bb0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fendo.2020.00250","article-title":"Elevated bone hardness under denosumab treatment, with persisting lower osteocyte viability during discontinuation","volume":"11","author":"Jahn-Rickert","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.bonr.2023.101703_bb0100","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jbmr.1490","article-title":"Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: a study of healthy individuals and patients with Cushing\u2019s syndrome","volume":"27","author":"Jensen","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2023.101703_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bone.2014.12.004","article-title":"A joined role of canopy and reversal cells in bone remodeling--lessons from glucocorticoid-induced osteoporosis","volume":"73","author":"Jensen","year":"2015","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.bonr.2023.101703_bb0110","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00198-017-4026-z","article-title":"Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population","volume":"28","author":"Jorgensen","year":"2017","journal-title":"Osteoporos.Int."},{"issue":"3","key":"10.1016\/j.bonr.2023.101703_bb0115","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz095","article-title":"Bone mineral density after transitioning from denosumab to alendronate","volume":"105","author":"Kendler","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bonr.2023.101703_bb0120","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.bonr.2023.101703_bb0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jc.2016-3170","article-title":"Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report","volume":"102","author":"Lamy","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bonr.2023.101703_bb0130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jbmr.3091","article-title":"Coupling of Bone resorption and formation in real time: new knowledge gained from human Haversian BMUs","volume":"32","author":"Lassen","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bonr.2023.101703_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/M20-0882","article-title":"Delayed Denosumab injections and fracture risk among patients with osteoporosis\u202f: a population-based cohort study","volume":"173","author":"Lyu","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.bonr.2023.101703_bb0140","doi-asserted-by":"crossref","first-page":"e4155","DOI":"10.1210\/clinem\/dgab321","article-title":"The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation","volume":"106","author":"Makras","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bonr.2023.101703_bb0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00223-017-0357-1","article-title":"Multiple vertebral osteonecroses (Kummell\u2019s disease) after 10\u00a0years on denosumab: is osteocyte apoptosis to blame?","volume":"102","author":"Maugars","year":"2018","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0150","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","article-title":"Observations following discontinuation of long-term denosumab therapy","volume":"28","author":"McClung","year":"2017","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0155","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2021.02.002","article-title":"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption","volume":"184","author":"McDonald","year":"2021","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bonr.2023.101703_bb0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bonr.2023.101703_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10412","article-title":"Zoledronic acid is not equally potent on osteoclasts generated from different individuals","volume":"4","author":"Moller","year":"2020","journal-title":"JBMR Plus"},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0170","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12020-016-1030-6","article-title":"Clinical vertebral fractures following denosumab discontinuation","volume":"54","author":"Polyzos","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.bonr.2023.101703_bb0175","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00198-015-3458-6","article-title":"Rebound-associated vertebral fractures after discontinuation of denosumab-from clinic and biomechanics","volume":"27","author":"Popp","year":"2016","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bonr.2023.101703_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10040787","article-title":"Osteoporosis treatment with anti-sclerostin antibodies-mechanisms of action and clinical application","volume":"10","author":"Rauner","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bonr.2023.101703_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bone.2018.03.019","article-title":"Bone histomorphometry in transiliac biopsies from 48 normal, healthy men","volume":"111","author":"Recker","year":"2018","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bonr.2023.101703_bb0190","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bonr.2023.101703_bb0195","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/jbmr.4098","article-title":"Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial","volume":"35","author":"Solling","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bonr.2023.101703_bb0200","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jbmr.4305","article-title":"Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study","volume":"36","author":"Solling","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2023.101703_bb0205","first-page":"75","article-title":"Multiple vertebral fractures after suspension of denosumab. A series of 56 cases","author":"Sosa-Henr\u00edquez","year":"2021","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00198-014-2851-x","article-title":"Age-related changes in vertebral and iliac crest 3D bone microstructure--differences and similarities","volume":"26","author":"Thomsen","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2023.101703_bb0215","article-title":"Glucocorticoids prolong the reversal-resorption phase delaying bone formation in intracortical remodelling compared to postmenopausal and osteoporotic women","volume":"14","author":"Thomsen","year":"2021","journal-title":"Bone Rep."},{"issue":"9886","key":"10.1016\/j.bonr.2023.101703_bb0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study","volume":"30","author":"Tsai","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1210\/clinem\/dgaa756","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2021","journal-title":"J. Clin. Endocrinol."},{"key":"10.1016\/j.bonr.2023.101703_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bone.2014.06.020","article-title":"Additive effect of PTH (1-34) and zoledronate in the prevention of disuse osteopenia in rats","volume":"66","author":"Vegger","year":"2014","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2023.101703_bb0240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41467-019-14003-6","article-title":"Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism","volume":"11","author":"Weivoda","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bonr.2023.101703_bb0245","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1177\/34.10.3745910","article-title":"Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification","volume":"34","author":"van de Wijngaert","year":"1986","journal-title":"J. Histochem. Cytochem."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187223000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187223000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:27:30Z","timestamp":1762446450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187223000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":49,"alternative-id":["S2352187223000517"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2023.101703","relation":{},"ISSN":["2352-1872"],"issn-type":[{"type":"print","value":"2352-1872"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection \u2013 A post-treatment re-initiation bone biopsy-based case study","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2023.101703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101703"}}